Skip to main content
Premium Trial:

Request an Annual Quote

NIH Grants for Pharmacogenomics Research FY 06

NIH Grants for Pharmacogenomics Research FY'05
January 1 – January 16*
City, State, or Country Name
Organization Name
Principal Investigator
Los Angeles
Cedars-Sinai Medical Center Magoffin, Denis A
Post-translational regulation of CYP17 activity
Los Angeles Cedars-Sinai Medical Center Wheeler, Christopher J
EGFR activity in T cell-influenced glioma invasiveness & chemosensitivity
Stanford Stanford University Shafer, Robert W
Identification of Multi-Drug Resistant HIV-1 Isolates
Davis University of California Davis Vanwinkle, Laura S
Gonadal vs. Genomic Influences on Xenobiotic Metabolism
Davis University of California Davis Conley,
Alan J
New Paradigms of P450-mediated Steroids Metabolism
Coral Gables
University of Miami — Medical Carraway, Kermit L
Functions of HER2/ErbB2 Ligand Sialomucin Complex/Muc4
Evanston Northwestern Healthcare Band, Hamid
Molecular Control of EGF Receptor Down-Regulation
Iowa City
University of Iowa Elcock, Adrian H
Computational and experimental studies of targets of protein kinase inhibitors
Boston University Charles River Campus Waxman, David J
Cytochrome P450-Endogenous Substrate Metabolism
Wayne State University Kocarek, Thomas A
Regulation of Hepatic P450s by Anti-Cholesterol Drugs
New York
University of Rochester Li, Willis X
Network Interaction between EGFR and TGFbeta Pathways
Stony Brook State University of New York Haltiwanger, Robert S
O-Glycosylation of Epidermal Growth Factor-like modules
Buffalo Roswell Park Cancer Institute Chadha, Kailash C
Biomarkers for Diagnosis and Management of Prostate Cancer
North Carolina
Chapel Hill
University of North Carolina Chapel Hill Givens, Raymond C
Blood Pressure Control by CYP3A Enzymes
Raleigh North Carolina University Raleigh Lalush,
David S
Data Analysis in Diagnositic Applications of Microarrays
Greenville East Carolina University Mccubrey, James A
Ras/Raf & PI3K/Akt Induced Breast Cancer Drug Resistance
Oregon Health and Science University Spencer, Peter S
(Neuro)toxicogenomics and Child Health
Temple University Reddy, E Premkumar
Novel Substrate Competitive Bcr-Abl Inhibitor Active Against Gleevec-Resistant CM
Vanderbilt University Ware, Lorraine B
Biomarker Profiles in the Diagnosis/Prognosis of ARDS
University of Texas Health Sciences Center at Houston Strobel, Henry W
CYPs/2D18 Limit Inflammation Cascade Following Brain Injury
University of Washington Rieder,
Mark J
Genetic Factors Influencing Warfarin Dose
Seattle University of Washington Rettie,
Allan E
Active Site Models of CYP4 Enzymes
*SOURCE: US National Institutes of Health

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.